Articles

Trump’s 50% tariffs on India kick in. Clothes, jewelry and shrimp are getting hit.

The U.S. doesn’t import as much from India as it does from trade partners such as China, Canada, Mexico or the European Union, but the increased levies will still be felt in certain industries.

Think the S&P 500 is too expensive? Check out these ETFs instead.

Some investors are worried that the stock market is set up for a tech-driven decline.

Did Covid-19 push older people out of the workforce?

The answer looks obvious, but raw data can be deceiving

My brother doesn’t qualify for Social Security. Can he get survivor benefits through his late wife’s disability insurance? 

“When he was working he was paid under the table for quite a few years.”

The 6 things to watch as Trump blitzes the Federal Reserve

President Trump has been putting pressure on Fed Chair Jerome Powell and his colleagues in multiple ways. Here are key things for investors to track.

Kohl’s stock soars as beauty products and impulse purchases set stage for a turnaround

Kohl’s sales are still in decline, but they came in better than expected during the latest quarter as the company benefited from a Sephora partnership and redesigned checkout lines.

Taylor Swift doesn’t need our financial advice — so why does she get so much of it?

Swift is the “Magnificent 7” of tech stocks rolled into one global superstar

Suze Orman shares her secret to financial independence — and how you can get there

The money and investing guru takes a hard line on spending, home ownership, college tuition, life insurance and target-date retirement funds

No one is expecting a global boom. This former hedge-fund manager says it’s coming and has a way to play it.

A global economic boom is on few radars right now. But what if it happens? The best way to play that involves an unpopular asset.

Forget about Fed rate cuts for a second — and worry about how markets are running so low on extra cash

The market’s financial plumbing may be tested in September by a rocky quarter-end period.

The bear case on Eli Lilly has played out, says only firm to have called it a sell

The bear case for Eli Lilly has now played out following the reaction to the drugmaker’s oral obesity drug trial, an analyst said Wednesday in upgrading the stock.

Lululemon faces lack of fashion cohesion and investor ‘frustration’ ahead of earnings. Here’s why.

As the athleisure company prepares to report quarterly results next week, some Wall Street analysts say they still don’t have a clear sense of why its North American business has stumbled.
1 34 35 36 37 38 2,302